5-cyclopropyl-3-methyl-1H-pyrazole, 95.0%, 250mg

5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-, hydrochloride (1:1), 100mg

5-methyl-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one, 95%, 5g

4-(4-Bromo-1H-pyrazol-3-yl)pyridine, 95.0%, 5g

tert-butyl 2-(4-methylphenyl)-5-(pyrrolidin-1-ylcarbonyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylate, 250mg

3-(ethoxycarbonyl)-1-(2-methoxyphenyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

3-Fluoro-4-(trifluoromethoxy)benzyl bromide, 1g

5-Bromovaleryl Chloride>98.0%(T)25g

Arctiin>97.0%(HPLC)50mg

2-(3-(Methoxymethyl)phenoxy)acetic acid, 98%, 100mg

5-methyl-4-phenyl-2-pyrimidinethiol, 95.0%, 250mg

Filtres pour seringues Minisart® NML Plus non stériles, 0,45 µm, 500 pièce(s)

(1-Benzyl-pyrrolidin-3-yl)-isopropyl-amine, 100mg